FRESH TRACKS THERAPEUTICS INCFRESH TRACKS THERAPEUTICS INCFRESH TRACKS THERAPEUTICS INC

FRESH TRACKS THERAPEUTICS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.05 M‬EUR
−1.28EUR
‪−5.16 M‬EUR
‪7.25 M‬EUR
‪5.87 M‬
Beta (1Y)
−1.40

About Fresh Tracks Therapeutics, Inc.

CEO
Albert N. Marchio
Headquarters
Boulder
Website
Employees (FY)
4
Founded
2009
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in September 2009 and is headquartered in Boulder, CO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VCC is 0.80 EUR — it hasn't changed in the past 24 hours. Watch FRESH TRACKS THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange FRESH TRACKS THERAPEUTICS INC stocks are traded under the ticker VCC.
VCC reached its all-time high on Jan 7, 2002 with the price of 6,075.00 EUR, and its all-time low was 0.07 EUR and was reached on Jul 5, 2022. View more price dynamics on VCC chart.
See other stocks reaching their highest and lowest prices.
VCC stock is 0% volatile and has beta coefficient of −1.40. Track FRESH TRACKS THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is FRESH TRACKS THERAPEUTICS INC there?
Today FRESH TRACKS THERAPEUTICS INC has the market capitalization of ‪5.05 M‬, it has decreased by 6.80% over the last week.
Yes, you can track FRESH TRACKS THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
FRESH TRACKS THERAPEUTICS INC is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.
VCC net income for the last quarter is ‪−1.12 M‬ EUR, while the quarter before that showed ‪1.80 M‬ EUR of net income which accounts for −162.17% change. Track more FRESH TRACKS THERAPEUTICS INC financial stats to get the full picture.
No, VCC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 22, 2024, the company has 4.00 employees. See our rating of the largest employees — is FRESH TRACKS THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FRESH TRACKS THERAPEUTICS INC EBITDA is ‪−5.69 M‬ EUR, and current EBITDA margin is −78.93%. See more stats in FRESH TRACKS THERAPEUTICS INC financial statements.
Like other stocks, VCC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRESH TRACKS THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRESH TRACKS THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRESH TRACKS THERAPEUTICS INC stock shows the sell signal. See more of FRESH TRACKS THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.